These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31954725)

  • 1. Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis.
    Henrot P; Moisan F; Laurent P; Manicki P; Kaulanjan-Checkmodine P; Jolivel V; Rezvani HR; Leroy V; Picard F; Boulon C; Schaeverbeke T; Seneschal J; Lazaro E; Taïeb A; Truchetet ME; Cario M
    J Invest Dermatol; 2020 Jul; 140(7):1427-1434.e5. PubMed ID: 31954725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.
    Truchetet ME; Demoures B; Eduardo Guimaraes J; Bertrand A; Laurent P; Jolivel V; Douchet I; Jacquemin C; Khoryati L; Duffau P; Lazaro E; Richez C; Seneschal J; Doutre MS; Pellegrin JL; Constans J; Schaeverbeke T; Blanco P; Contin-Bordes C;
    Arthritis Rheumatol; 2016 Nov; 68(11):2784-2794. PubMed ID: 27429171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes.
    Henrot P; Pain C; Taïeb A; Truchetet ME; Cario M
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):895-898. PubMed ID: 32633087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome.
    Lemaire R; Farina G; Bayle J; Dimarzio M; Pendergrass SA; Milano A; Perbal B; Whitfield ML; Lafyatis R
    J Invest Dermatol; 2010 Jun; 130(6):1514-23. PubMed ID: 20182440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
    Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
    Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F
    Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
    Peidl A; Perbal B; Leask A
    PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
    Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
    J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Roles of CCN3 Protein in Immune-Related Diseases.
    Peng L; Wei Y; Shao Y; Li Y; Liu N; Duan L
    Mediators Inflamm; 2021; 2021():5576059. PubMed ID: 34393649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
    Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
    J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCN proteins as potential actionable targets in scleroderma.
    Henrot P; Truchetet ME; Fisher G; Taïeb A; Cario M
    Exp Dermatol; 2019 Jan; 28(1):11-18. PubMed ID: 30329180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin.
    Apostolidis SA; Stifano G; Tabib T; Rice LM; Morse CM; Kahaleh B; Lafyatis R
    Front Immunol; 2018; 9():2191. PubMed ID: 30327649
    [No Abstract]   [Full Text] [Related]  

  • 16. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
    Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
    Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.